Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for SRx Health Solutions (SRXH) over the last 9 years, with Q2 2025 value amounting to $278000.0.

  • SRx Health Solutions' Gains from Investment Securities rose 18380.96% to $278000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $1.9 million, marking a year-over-year increase of 183562.22%. This contributed to the annual value of $54.0 for FY2023, which is 2285.71% down from last year.
  • According to the latest figures from Q2 2025, SRx Health Solutions' Gains from Investment Securities is $278000.0, which was up 18380.96% from $97854.0 recorded in Q1 2025.
  • Over the past 5 years, SRx Health Solutions' Gains from Investment Securities peaked at $6.5 million during Q1 2021, and registered a low of -$29.4 million during Q2 2021.
  • Its 5-year average for Gains from Investment Securities is -$1.5 million, with a median of $92000.0 in 2024.
  • As far as peak fluctuations go, SRx Health Solutions' Gains from Investment Securities surged by 57012.33% in 2021, and later plummeted by 1208044.01% in 2024.
  • Quarter analysis of 5 years shows SRx Health Solutions' Gains from Investment Securities stood at -$590000.0 in 2021, then surged by 186.78% to $512000.0 in 2022, then surged by 207.62% to $1.6 million in 2023, then tumbled by 94.16% to $92000.0 in 2024, then soared by 202.17% to $278000.0 in 2025.
  • Its last three reported values are $278000.0 in Q2 2025, $97854.0 for Q1 2025, and $92000.0 during Q4 2024.